Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade With Nonbiologic DMARDs

American Journal of Medicine - United States
doi 10.1016/j.amjmed.2013.02.016
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

The Protective Effect of IL-6 Blockade on Glucose and Cardiovascular Risk in Patients With Active Rheumatoid Arthritis

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2001English

Il-4Rα, TNF-α,TNF-α Receptor, and CD4 Enhancer Genes Polymorphisms in Rheumatoid Arthritis Saudi Female Patients

IOSR Journal of Dental and Medical Sciences
2014English

TNF-α-Blockade Unter Praxisbedingungen

hautnah dermatologie
2011English

Aspirin Use in Rheumatoid Arthritis Patients With Increased Risk of Cardiovascular Disease

ISRN Rheumatology
2013English

Quality of Life in Rheumatoid Arthritis Patients Taking Combination DMARDs

Journal of Medical Science And clinical Research
2017English

Cardiovascular Risk Assessment in Rheumatoid Arthritis With Nodulosis: Approach to Primary Prevention

Romanian Journal of Rheumatology
2019English

Tumor Necrosis Factor-Α Blockade Treatment Decreased CD154 (CD40-ligand) Expression in Rheumatoid Arthritis

PLoS ONE
Multidisciplinary
2017English

Is Rheumatoid Arthritis a Cardiovascular Risk Equivalent to Diabetes?

Arthritis Care and Research
Rheumatology
2018English

IL-17/TNF-α BISPECIFIC ANTIBODIES AS NEW THERAPEUTIC APPROACH TO RHEUMATOID ARTHRITIS

TURKISH MEDICAL STUDENT JOURNAL
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy